Cargando…

CEA-Ki-67- Pathologic Subtype: An Adjunct Factor for Refining Prognosis in Stage I Pulmonary Adenocarcinoma

OBJECTIVES: The prognosis for stage I pulmonary adenocarcinoma is generally good. However, some patients with stage I pulmonary adenocarcinoma have an unexpectedly poor outcome. This warrants consideration of adjunct markers. In this study, we analyze carcinoembryonic antigen, Ki-67, and a pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Dongzhi, Sun, Yanbin, McNutt, Michael A., Xu, Shun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082601/ https://www.ncbi.nlm.nih.gov/pubmed/35548181 http://dx.doi.org/10.3389/fsurg.2022.853363

Ejemplares similares

Pre-operative Prediction of Ki-67 Expression in Various Histological Subtypes of Lung Adenocarcinoma Based on CT Radiomic Features
por: Huang, Zhiwei, et al.
Publicado: (2021)

The relationship between Ki-67 expression and imaging signs and pathological features in GISTs
por: Xiao, Lin, et al.
Publicado: (2023)

Ki67 and the apparent diffusion coefficient in postoperative prostate cancer with endocrine therapy
por: He, Jun, et al.
Publicado: (2023)

Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2− Early Breast Cancer Patients
por: Li, Shuai, et al.
Publicado: (2022)

Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin
por: Yan, Fengcai, et al.
Publicado: (2021)

Apoptosis and Ki-67 as predictive factors for response to radiation therapy in feline nasal lymphomas
por: FU, Dah-Renn, et al.
Publicado: (2016)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

A Preliminary Analysis of Ki-67 Expression in Breast Cancer in the Caribbean
por: Jogie, Joshua A, et al.
Publicado: (2023)

Expression of Kruppel-like factor 8 and Ki67 in lung adenocarcinoma and prognosis
por: Liu, Yifei, et al.
Publicado: (2017)

Molecular subtyping of ependymoma and prognostic impact of Ki-67
por: Lim, Ka Young, et al.
Publicado: (2021)

Prognostic Utility of Apoptosis Index, Ki-67 and Survivin Expression in Dogs with Nasal Carcinoma Treated with Orthovoltage Radiation Therapy
por: FU, Dah-Renn, et al.
Publicado: (2014)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
por: Zeng, Ming, et al.
Publicado: (2021)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
por: Keam, Bhumsuk, et al.
Publicado: (2011)

Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
por: Bouzubar, N., et al.
Publicado: (1989)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Clinicopathological characteristics of peripheral clinical stage IA lung adenocarcinoma with high Ki-67 expression
por: Liu, Zhan, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
por: Sadeghian, Dorsay, et al.
Publicado: (2022)

Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus
por: Volkweis, Bernardo Silveira, et al.
Publicado: (2012)

Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma
por: Azizan, Nornazirah, et al.
Publicado: (2018)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
por: Pergolini, I., et al.
Publicado: (2019)

Spectral CT imaging parameters and Ki-67 labeling index in lung adenocarcinoma
por: Chen, Mailin, et al.
Publicado: (2020)

Correlation between preoperative inflammatory markers, Ki-67 and the pathological grade of glioma
por: Xu, Guangda, et al.
Publicado: (2021)

Ki-67 and Its Relation With Complete Pathological Response in Patients With Breast Cancer
por: Wajid, Sana, et al.
Publicado: (2021)

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67
por: Sipos, Tamás-Csaba, et al.
Publicado: (2023)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.
por: Pujol, J. L., et al.
Publicado: (1996)

Ki67 Antigen as a Predictive Factor for Prognosis of Sinonasal Mucosal Melanoma
por: Kim, Dong-Kyu, et al.
Publicado: (2008)

CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis
por: LU, CANRONG, et al.
Publicado: (2013)

Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
por: Böger, Christine, et al.
Publicado: (2015)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Correlation between expression of Ki-67 and MSCT signs in different types of lung adenocarcinoma
por: Yan, Jingang, et al.
Publicado: (2020)

Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors
por: Wang, Hai-Yue, et al.
Publicado: (2019)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebt54v70i95l17p639qvg59848